Gui Huang

621 total citations
19 papers, 496 citations indexed

About

Gui Huang is a scholar working on Molecular Biology, Cancer Research and Biomedical Engineering. According to data from OpenAlex, Gui Huang has authored 19 papers receiving a total of 496 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Cancer Research and 5 papers in Biomedical Engineering. Recurrent topics in Gui Huang's work include Nanoplatforms for cancer theranostics (5 papers), Nanoparticle-Based Drug Delivery (3 papers) and Cancer-related molecular mechanisms research (3 papers). Gui Huang is often cited by papers focused on Nanoplatforms for cancer theranostics (5 papers), Nanoparticle-Based Drug Delivery (3 papers) and Cancer-related molecular mechanisms research (3 papers). Gui Huang collaborates with scholars based in China and United States. Gui Huang's co-authors include Na Zhang, Wen Xu, Xuenong Zhang, Wenjun Wan, Jiang Wu, Yan Zhang, Jing Hong, Qianglin Zeng, Yamei Zhang and Xia Jin and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Scientific Reports.

In The Last Decade

Gui Huang

18 papers receiving 490 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gui Huang China	11	297	126	94	87	85	19	496
Suyash M. Patil United States	10	257 0.9×	72 0.6×	74 0.8×	75 0.9×	64 0.8×	14	470
Seong Dong Jeong South Korea	11	172 0.6×	73 0.6×	71 0.8×	87 1.0×	32 0.4×	19	441
Min‐zheng Zhu China	13	300 1.0×	93 0.7×	24 0.3×	52 0.6×	34 0.4×	18	491
Cheng‐mei Tian China	13	316 1.1×	100 0.8×	24 0.3×	52 0.6×	33 0.4×	24	534
Minyan Chen China	11	224 0.8×	69 0.5×	42 0.4×	70 0.8×	21 0.2×	34	431
Tushar Date India	14	201 0.7×	40 0.3×	134 1.4×	103 1.2×	190 2.2×	22	493
Michael A. Sandoval United States	12	215 0.7×	36 0.3×	163 1.7×	98 1.1×	185 2.2×	15	500
Roshan Goswami United States	6	237 0.8×	29 0.2×	79 0.8×	49 0.6×	71 0.8×	7	369
Mengdi Song China	7	176 0.6×	64 0.5×	25 0.3×	100 1.1×	79 0.9×	11	364
Rowshan Ara Islam Malaysia	8	197 0.7×	40 0.3×	36 0.4×	56 0.6×	81 1.0×	11	349

Countries citing papers authored by Gui Huang

Since Specialization

Citations

This map shows the geographic impact of Gui Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gui Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gui Huang more than expected).

Fields of papers citing papers by Gui Huang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gui Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gui Huang. The network helps show where Gui Huang may publish in the future.

Co-authorship network of co-authors of Gui Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Gui Huang. A scholar is included among the top collaborators of Gui Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gui Huang. Gui Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Zhao, Ying‐Yong, Zhixin Yao, Gui Huang, et al.. (2024). Dexamethasone Pretreatment Potentiates a Folic Acid-Functionalized Delivery System for Enhanced Lung Cancer Therapy. Molecular Pharmaceutics. 21(3). 1077–1089. 4 indexed citations

Zhao, Kelei, Qianglin Zeng, Yige Zhang, et al.. (2023). Evolution of lasR mutants in polymorphic Pseudomonas aeruginosa populations facilitates chronic infection of the lung. Nature Communications. 14(1). 5976–5976. 25 indexed citations

Chen, Gang, Xiaomei Zhao, Gui Huang, et al.. (2023). Tumor immunosuppression relief via acidity modulation combined PD-L1 siRNA for enhanced immunotherapy. Biomaterials Advances. 150. 213425–213425. 10 indexed citations

Zeng, Qianglin, et al.. (2023). Diagnostic and prognostic value of Ang-2 in ARDS: a systemic review and meta-analysis. Expert Review of Respiratory Medicine. 17(7). 597–606. 4 indexed citations

Wang, Yu, Xiaomei Zhao, Gui Huang, et al.. (2022). A multifunctional non-viral vector for the delivery of MTH1-targeted CRISPR/Cas9 system for non-small cell lung cancer therapy. Acta Biomaterialia. 153. 481–493. 33 indexed citations

Huang, Gui, et al.. (2021). Efficacy of external fixation of a straight silicone stent in the treatment of subglottic stenosis. Annals of Palliative Medicine. 10(1). 194–201. 2 indexed citations

Wan, Wenjun, Gui Huang, Yu Wang, et al.. (2021). Coadministration of iRGD peptide with ROS-sensitive nanoparticles co-delivering siFGL1 and siPD-L1 enhanced tumor immunotherapy. Acta Biomaterialia. 136. 473–484. 41 indexed citations

Wang, Yu, et al.. (2021). Lactate Consumption via Cascaded Enzymes Combined VEGF siRNA for Synergistic Anti‐Proliferation and Anti‐Angiogenesis Therapy of Tumors. Advanced Healthcare Materials. 10(19). e2100799–e2100799. 41 indexed citations

Wang, Dandan, Weiliang Chen, Hui Li, et al.. (2020). Folate-receptor mediated pH/reduction-responsive biomimetic nanoparticles for dually activated multi-stage anticancer drug delivery. International Journal of Pharmaceutics. 585. 119456–119456. 21 indexed citations

10.

Huang, Gui, et al.. (2019). Transcription factor Nrf2 induces the up-regulation of lncRNA TUG1 to promote progression and adriamycin resistance in urothelial carcinoma of the bladder. Cancer Management and Research. Volume 11. 6079–6090. 31 indexed citations

11.

Huang, Gui, et al.. (2019). Involvement of ABC transporters in the efflux and toxicity of MPA‐COOH‐CdTe quantum dots in human breast cancer SK‐BR‐3 cells. Journal of Biochemical and Molecular Toxicology. 33(8). e22343–e22343. 7 indexed citations

12.

Li, Lin, Caixia Liu, Jun Zhao, et al.. (2019). ALK actionable mutations (muts) within cancer types and their responses to crizotinib (CZ).. Journal of Clinical Oncology. 37(15_suppl). e14739–e14739.

13.

Huang, Gui, et al.. (2019). Synthesis of theranostic Anti-EGFR ligand conjugate iron oxide nanoparticles for magnetic resonance imaging for treatment of liver cancer. Journal of Drug Delivery Science and Technology. 55. 101367–101367. 12 indexed citations

14.

Zhang, Yan, et al.. (2018). Clinicopathological significance of DAPK promoter methylation in non-small-cell lung cancer: a systematic review and meta-analysis. Cancer Management and Research. Volume 10. 6897–6904. 8 indexed citations

15.

Zhang, Yan, et al.. (2018). Long noncoding RNA MEG3 inhibits breast cancer growth via upregulating endoplasmic reticulum stress and activating NF‐κB and p53. Journal of Cellular Biochemistry. 120(4). 6789–6797. 77 indexed citations

16.

Zhang, Yan, et al.. (2018). Increased DHRS12 Expression Independently Predicts Poor Survival in Patients with High-Grade Serous Ovarian Cancer. Future Oncology. 14(25). 2579–2588. 2 indexed citations

17.

Zeng, Qianglin, Dandan Li, Gui Huang, et al.. (2016). Time series analysis of temporal trends in the pertussis incidence in Mainland China from 2005 to 2016. Scientific Reports. 6(1). 32367–32367. 45 indexed citations

18.

Huang, Gui, Jiang Wu, Shaofeng Shui, et al.. (2016). Calreticulin Promotes Proliferation and Migration But Inhibits Apoptosis in Schwann Cells. Medical Science Monitor. 22. 4516–4522. 5 indexed citations

19.

Zhang, Na, et al.. (2005). Investigation of lectin-modified insulin liposomes as carriers for oral administration. International Journal of Pharmaceutics. 294(1-2). 247–259. 128 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact